70 results
Page 3 of 4
6-K
EX-99.1
cg0bdhdlv9wjiu2y0
6 Oct 20
Gamida Cell Announces Positive Topline Data on Secondary Endpoints from Phase 3 Clinical Study of Omidubicel in Patients with Hematologic Malignancies
6:49am
6-K
4k4bsshkcqzet 8znw28
12 Aug 20
Report of Foreign Private Issuer
8:27am
6-K
EX-99.3
t7xbhlp0qwsb vi
12 Aug 20
Report of Foreign Private Issuer
8:27am
6-K
EX-99.1
vi2bkxy
6 Aug 20
Report of Foreign Private Issuer
4:02pm
6-K
EX-1.1
p1zxrbsasfbdva wpsf
20 May 20
Gamida Cell Announces Pricing of $60 Million Public Offering of Ordinary Shares
4:14pm
424B5
p48c9vcyodzgkav gvtf
20 May 20
Prospectus supplement for primary offering
4:08pm
6-K
0rnlu2
18 May 20
Gamida Cell Announces Launch of Public Offering of Ordinary Shares
4:12pm
424B5
dtoqqcubas99vspa4 sj
18 May 20
Prospectus supplement for primary offering
4:11pm
F-3
EX-1.2
t0dbk18l0 g7
14 Nov 19
Shelf registration (foreign)
5:11pm
424B4
ziqhmzzhkvfa 0w0y33o
28 Jun 19
Prospectus supplement with pricing info
3:51pm
F-1/A
ru9k32v7z66m5p
26 Jun 19
Registration statement (foreign) (amended)
12:00am
F-1
EX-1.1
097os
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
6dml4j74hz58o7xzzar
24 Jun 19
Registration statement (foreign)
4:04pm
CORRESP
1h1vz05ep40 db4
24 Jun 19
Correspondence with SEC
12:00am
6-K
EX-99.1
s2f 9a5xld
19 Jun 19
Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel
6:02am
6-K
EX-99.1
dvqlqz
1 May 19
Current report (foreign)
7:23am
6-K
w1ss qsy5
21 Mar 19
Gamida Cell Nominates Two Healthcare Industry Veterans to Its Board of Directors
5:23pm
6-K
EX-99.1
cxh1g2sc2gkpn122o387
21 Mar 19
Gamida Cell Nominates Two Healthcare Industry Veterans to Its Board of Directors
5:23pm
20-F
iya6xei
25 Feb 19
Annual report (foreign)
5:08pm